BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33456348)

  • 1. Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.
    Cai W; Liu X; Ge W; Wu D; Xu J; Bai R; Hu H
    Int J Med Sci; 2021; 18(4):911-920. PubMed ID: 33456348
    [No Abstract]   [Full Text] [Related]  

  • 2. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors.
    Sultan I; Qaddoumi I; Rodríguez-Galindo C; Nassan AA; Ghandour K; Al-Hussaini M
    Pediatr Blood Cancer; 2010 Jan; 54(1):35-40. PubMed ID: 19798737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of early and aggressive post-operative radiation therapy in improving outcome for pediatric central nervous system atypical teratoid/rhabdoid tumor.
    Yang WC; Yen HJ; Liang ML; Chen HH; Lee YY; Wong TT; Hu YW; Chen YW
    Childs Nerv Syst; 2019 Jun; 35(6):1013-1020. PubMed ID: 30982172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators.
    Zhuge Y; Cheung MC; Yang R; Perez EA; Koniaris LG; Sola JE
    J Surg Res; 2010 Oct; 163(2):257-63. PubMed ID: 20538287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors.
    Islam M; Saltzman AF; Amini A; Carrasco A; Cost NG
    Urology; 2018 Oct; 120():222-230. PubMed ID: 30076944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and survival in non-central nervous system rhabdoid tumors.
    Farber BA; Shukla N; Lim II; Murphy JM; La Quaglia MP
    J Pediatr Surg; 2017 Mar; 52(3):373-376. PubMed ID: 27639430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
    Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
    Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
    Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
    Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Outcomes and Predictors of Primary Central Nervous System Melanoma: A SEER-Based Study.
    Man W; Wang G
    World Neurosurg; 2019 Sep; 129():e782-e790. PubMed ID: 31203063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of disseminated central nervous system malignant rhabdoid tumor.
    Olson TA; Bayar E; Kosnik E; Hamoudi AB; Klopfenstein KJ; Pieters RS; Ruymann FB
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):71-5. PubMed ID: 7743242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis.
    Quinn TJ; Almahariq MF; Siddiqui ZA; Thompson AB; Hamstra DA; Kabolizadeh P; Gowans KL; Chen PY
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27969. PubMed ID: 31464041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
    Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
    World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant rhabdoid tumor of the central nervous system.
    Bhattacharjee M; Hicks J; Dauser R; Strother D; Chintagumpala M; Horowitz M; Cooley L; Vogel H
    Ultrastruct Pathol; 1997; 21(4):361-8. PubMed ID: 9206001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.
    Lafay-Cousin L; Hawkins C; Carret AS; Johnston D; Zelcer S; Wilson B; Jabado N; Scheinemann K; Eisenstat D; Fryer C; Fleming A; Mpofu C; Larouche V; Strother D; Bouffet E; Huang A
    Eur J Cancer; 2012 Feb; 48(3):353-9. PubMed ID: 22023887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.
    von Hoff K; Hinkes B; Dannenmann-Stern E; von Bueren AO; Warmuth-Metz M; Soerensen N; Emser A; Zwiener I; Schlegel PG; Kuehl J; Frühwald MC; Kortmann RD; Pietsch T; Rutkowski S
    Pediatr Blood Cancer; 2011 Dec; 57(6):978-85. PubMed ID: 21796761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.